Intraperitoneal injections with obacunone (2.5, 5, and 10 mg/kg) effectively alleviated LPS-induced ALI in mice by activating NRF2 and inhibiting NRF2 ubiquitinated proteasome degradation. This evidence concerns the gene NFE2L2 and acute respiratory distress syndrome.